Factors impacting the delivery of therapeutic levels of pyrone-based HIV protease inhibitors

Pharm Biotechnol. 1998:11:211-32. doi: 10.1007/0-306-47384-4_10.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Drug Delivery Systems
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / pharmacokinetics*
  • Humans
  • Metabolic Clearance Rate
  • Protein Binding
  • Structure-Activity Relationship

Substances

  • HIV Protease Inhibitors